Glenmark Pharmaceuticals informs about updates

18 Jun 2025 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Glenmark Pharmaceuticals has informed that the United States Food & Drug Administration (USFDA) conducted a GMP inspection at the Company’s manufacturing facility situated in Monroe, North Carolina, USA from 09 June 2025 to 17 June 2025. At the end of the inspection, the Company was issued a Form 483 with five (5) observations. All the observations are procedural in nature. There was no observation related to data integrity reported. The Company will work in close collaboration with the agency to address the observations and will respond to the USFDA within the stipulated timeline. 

The above information is a part of company’s filings submitted to BSE.


Glenmark Pharma Share Price

1965.75 -8.40 (-0.43%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×